Back in June, I had the opportunity to pick the mind of the brilliant Jon Sockell, Co-founder and COO of Limbix. Limbix Spark is the first prescription digital therapeutic designed to support adolescents with depression.
Among many other things, our conversation touched on Jon’s professional journey and Limbix’s innovative business model. We also discussed clinical and real-world evidence for digital therapeutics along with the future of VR, mobile health apps, and digital therapeutics in healthcare and mental health in the post-COVID new normal. Further, we dissected the idea of a “digital pharmacy” and how this might look in the future.
You can watch the whole Fireside Chat with Jon Sockell from Limbix or listen to the podcast version below.
About Impetus Digital
Impetus Digital is the spark behind sustained healthcare stakeholder communication, collaboration, education, and insight synthesis. Our best-in-class technology and professional services ensure that life science organizations around the world can easily and cost-effectively grow and prosper—from brand or idea discovery to development, commercialization, execution, and beyond—in collaboration with colleagues, customers, healthcare providers, payers, and patients.